軟部組織修復の世界市場：製品別、用途別、エンドユーザー別、地域別 - 2030年までの予測

軟部組織修復の市場規模は、2025年の1,590万米ドルから2030年には2,050万米ドルに達し、2025年から2030年までのCAGRは5.1%で成長すると予測されています。

軟部組織修復器具と消耗品の主な目的は、損なわれた組織を強化すること、あるいは断裂や損傷を受けた軟部組織構造に外科的に対処することです。この分野の堅調な市場成長は、軟部組織修復の様々なサブフィールドにおける革新的な製品の普及、若者層におけるスポーツ関連傷害の発生率の増加、整形外科的軟部組織傷害やヘルニアになりやすい高齢化など、いくつかの重要な要因に起因しています。さらに、特にラテンアメリカとアジア太平洋地域では、医療システムへの政府投資の増加や可処分所得の上昇と相まって、ヘルスケア・インフラの進歩が市場の拡大を大きく後押ししています。しかし、保険償還の制限、複雑な規制状況、外科的介入に伴う高額費用など、進展を妨げる課題も残されています。

組織パッチ/メッシュ分野は、主にヘルニア修復、骨盤臓器脱、損なわれた軟部組織の補強や置換を必要とする様々な再建術における広範な用途により、2024年の軟部組織修復市場で最大のシェアを占めました。これらの製品の優位性は、構造的支持能力、手術時間の短縮、患者の転帰の改善に起因しています。在来組織との統合性を高め、合併症の発生率が低い生物学的メッシュと合成メッシュの両方の採用が増加していることが、需要をさらに押し上げています。軽量、生体適合性、吸収性ポリマーの開発に焦点を当てた最近のメッシュ技術の動向は、その臨床的受容性を著しく高め、用途を拡大しています。さらに、肥満の増加、高齢化、組織の補強や再建を必要とする手術の増加も、このセグメントの堅調な成長に寄与しています。さらに、新興国市場におけるヘルニアや軟部組織の修復手術に対する有利な償還状況は、パッチやメッシュの採用を促進し、それによって製品ポートフォリオの中で主導的な役割を確固たるものにしています。

軟部組織修復市場における用途タイプ別では、皮膚修復が第3位のセグメントを占めています。この分野に影響を与える主な要因は、糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍などの効果的な皮膚修復介入を必要とする慢性創傷の高い普及率です。熱傷や外傷性皮膚創傷の増加により、高度な創傷ケアや皮膚移植ソリューションの需要がさらに高まっています。コラーゲンドレッシング、成長因子治療、生体工学的代用皮膚など、創傷治療技術における最近の進歩は、治療効果を著しく向上させています。さらに、タイムリーな創傷管理の重要性に対する患者やヘルスケア従事者の意識の高まりが、この市場の拡大に大きな役割を果たしています。多くの新興国市場で慢性創傷治療に対する保険適用が拡大していることも、軟部組織修復市場の中で皮膚修復分野の持続的成長に寄与しています。

病院と診療所が市場シェアを独占しているのは、その大きな患者処理能力によるところが大きく、日常的な処置から複雑な外科的介入に至るまで、幅広い治療に対する需要を牽引しています。これらの施設は、高度な軟部組織修復技術を必要とする外傷、スポーツ関連傷害、その他の疾患などの急性症状に対する主要なアクセスポイントであることが多いです。高度な資格を持つ医療スタッフと洗練されたインフラを備えた病院は、スポーツ医学、一般外科、整形外科などの専門科を備え、総合的な診断能力と外科的介入を可能にしていることが多いです。さらに、大規模な病院や総合ケア・クリニックは、スケールメリットを生かし、最先端の手術製品や最先端技術を調達することができます。これらの病院は、多額の資金と大手医療機器メーカーとの確立された関係により、患者ケアにおける革新的なソリューションの採用・導入能力を高めています。

欧州が軟部組織修復市場で第2位の地位にあるのは、様々な要素が組み合わさっているためです。強力なヘルスケアインフラがこの地域を支えており、高度な外科手術や技術へのアクセスが広く普及しています。高齢者人口の増加に伴い、加齢に関連したヘルニアや整形外科的疾患が増加しているため、軟部組織修復のニーズが高まっています。欧州諸国には強力な償還制度があり、規制環境も整っているため、革新的な医療機器の導入が進んでいます。この地域は、早期の手術手技の広範な採用や大手医療機器企業の設立とともに、ヘルスケア研究のための持続的な資金援助によって支えられています。欧州における軟部組織修復製品の需要は、低侵襲治療や術後の改善に関する患者やヘルスケア専門家の意識の高まりとともに勢いを増しています。

当レポートでは、世界の軟部組織修復市場について調査し、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

• イントロダクション
• 市場力学
• エコシステム分析
• 価格分析
• サプライチェーン分析
• 特許分析
• バリューチェーン分析
• 技術分析
• 貿易分析
• 2025年～2026年の主な会議とイベント
• 規制分析
• ポーターのファイブフォース分析
• 主要な利害関係者と購入基準
• 顧客のビジネスに影響を与える動向/混乱
• ケーススタディ分析
• 投資と資金調達のシナリオ
• 償還シナリオ分析
• エンドユーザーの期待
• AI/生成AIが軟部組織修復市場に与える影響
• 2025年の米国関税が軟部組織修復市場に与える影響

第6章 軟部組織修復市場（製品別）

• イントロダクション
• 組織パッチ/メッシュ
• 腹腔鏡器具
• その他

第7章 軟部組織修復市場（用途別）

• イントロダクション
• ヘルニア修復
• 肌の修復
• 整形外科的軟部組織修復
• 歯科軟部組織修復
• 乳房再建
• 硬膜修復
• 膣スリング
• その他

第8章 軟部組織修復市場（エンドユーザー別）

• イントロダクション
• 病院・クリニック
• 外来手術センター
• その他

第9章 軟部組織修復市場（地域別）

• イントロダクション
• 北米
  • 北米のマクロ経済見通し
  • 米国
  • カナダ
• 欧州
  • 欧州のマクロ経済見通し
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • アジア太平洋のマクロ経済見通し
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他
• ラテンアメリカ
  • ラテンアメリカのマクロ経済見通し
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
• GCC諸国

第10章 競合情勢

• イントロダクション
• 主要参入企業の戦略/強み
• 収益分析、2020年～2024年
• 市場シェア分析、2024年
• 企業評価マトリックス：主要参入企業、2024年
• 企業評価マトリックス：スタートアップ/中小企業、2024年
• 企業評価と財務指標
• 研究開発費
• ブランド/製品比較
• 競合シナリオ

第11章 企業プロファイル

• 主要参入企業
  • ARTHREX, INC.
  • SMITH & NEPHEW PLC
  • JOHNSON & JOHNSON SERVICES, INC.
  • BECTON, DICKINSON AND COMPANY（BD）
  • STRYKER
  • MEDTRONIC
  • ZIMMER BIOMET
  • INTEGRA LIFESCIENCES CORPORATION
  • ARTIVION, INC.
  • ORGANOGENESIS INC.
  • LIFENET HEALTH
  • BAXTER
  • TISSUE REGENIX
  • CONMED CORPORATION
  • MERIL LIFE SCIENCES PVT. LTD.
  • RTI SURGICAL
• その他の企業
  • SAMYANG HOLDINGS CORPORATION
  • AROA BIOSURGERY LIMITED
  • ACERA SURGICAL INC.
  • ORTHOCELL LTD.
  • ACELL, INC.
  • BIOCER ENTWICKLUNGS-GMBH
  • ISTO BIOLOGICS
  • BETATECH MEDICAL
  • MIMEDX GROUP, INC.

第12章 付録

List of Tables

• TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
• TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS
• TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS
• TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
• TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD)
• TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM
• TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022-2024 (USD)
• TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
• TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022-2024 (USD)
• TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS
• TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
• TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER'S FIVE FORCES
• TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
• TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
• TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
• TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
• TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
• TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS
• TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
• TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
• TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
• TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 67 US: KEY MACROINDICATORS
• TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 74 CANADA: KEY MACROINDICATORS
• TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 88 GERMANY: KEY MACROINDICATORS
• TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 95 FRANCE: KEY MACROINDICATORS
• TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 102 UK: KEY MACROINDICATORS
• TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 109 ITALY: KEY MACROINDICATORS
• TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 116 SPAIN: KEY MACROINDICATORS
• TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 136 JAPAN: KEY MACROINDICATORS
• TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 143 CHINA: KEY MACROINDICATORS
• TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 150 INDIA: KEY MACROINDICATORS
• TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 157 AUSTRALIA: KEY MACROINDICATORS
• TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 164 SOUTH KOREA: KEY MACROINDICATORS
• TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 184 BRAZIL: KEY MACROINDICATORS
• TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 191 MEXICO: KEY MACROINDICATORS
• TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
• TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION
• TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT
• TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT
• TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT
• TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT
• TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
• TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
• TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022-APRIL 2025
• TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022-APRIL 2025
• TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025
• TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW
• TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED
• TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW
• TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED
• TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022-APRIL 2025
• TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022-APRIL 2025
• TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022-APRIL 2025
• TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
• TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
• TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022-APRIL 2025
• TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
• TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
• TABLE 239 STRYKER: COMPANY OVERVIEW
• TABLE 240 STRYKER: PRODUCTS OFFERED
• TABLE 241 MEDTRONIC: COMPANY OVERVIEW
• TABLE 242 MEDTRONIC: PRODUCTS OFFERED
• TABLE 243 MEDTRONIC: DEALS, JANUARY 2022-APRIL 2025
• TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022-APRIL 2025
• TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022-APRIL 2025
• TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
• TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
• TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022-APRIL 2025
• TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
• TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
• TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW
• TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED
• TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW
• TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED
• TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW
• TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED
• TABLE 257 BAXTER: COMPANY OVERVIEW
• TABLE 258 BAXTER: PRODUCTS OFFERED
• TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW
• TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED
• TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW
• TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED
• TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
• TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
• TABLE 265 RTI SURGICAL: COMPANY OVERVIEW
• TABLE 266 RTI SURGICAL: PRODUCTS OFFERED
• TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
• TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
• TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW
• TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW
• TABLE 271 ACELL, INC.: COMPANY OVERVIEW
• TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
• TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW
• TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW
• TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 SOFT TISSUE REPAIR MARKET SEGMENTATION & REGIONAL SCOPE
• FIGURE 2 SOFT TISSUE REPAIR MARKET: YEARS CONSIDERED
• FIGURE 3 SOFT TISSUE REPAIR MARKET: RESEARCH DESIGN
• FIGURE 4 SOFT TISSUE REPAIR MARKET: KEY DATA FROM SECONDARY SOURCES
• FIGURE 5 SOFT TISSUE REPAIR MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE)
• FIGURE 6 SOFT TISSUE REPAIR MARKET: KEY DATA FROM PRIMARY SOURCES
• FIGURE 7 SOFT TISSUE REPAIR MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
• FIGURE 8 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 9 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
• FIGURE 10 SOFT TISSUE REPAIR MARKET: MARKET SIZE ESTIMATION
• FIGURE 11 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (SUPPLY SIDE) (2024)
• FIGURE 12 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) (2024)
• FIGURE 13 SOFT TISSUE REPAIR MARKET: TOP-DOWN APPROACH
• FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SOFT TISSUE REPAIR MARKET
• FIGURE 15 SOFT TISSUE REPAIR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024)
• FIGURE 16 SOFT TISSUE REPAIR MARKET: DATA TRIANGULATION
• FIGURE 17 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
• FIGURE 18 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
• FIGURE 19 SOFT TISSUE REPAIR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 20 REGIONAL SNAPSHOT OF SOFT TISSUE REPAIR MARKET
• FIGURE 21 INCREASING NUMBER OF HERNIA REPAIR SURGERIES AND RISING R&D INVESTMENTS TO DRIVE MARKET
• FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 23 JAPAN AND TISSUE PATCHES/MESHES COMMANDED LARGEST MARKET SHARE IN 2024
• FIGURE 24 CANADA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
• FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
• FIGURE 26 SOFT TISSUE REPAIR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 27 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
• FIGURE 28 SOFT TISSUE REPAIR MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 29 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SOFT TISSUE REPAIR (JANUARY 2014-APRIL 2025)
• FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES) FOR SOFT TISSUE REPAIR PATENTS, 2014-2025
• FIGURE 31 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS
• FIGURE 32 SOFT TISSUE REPAIR MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
• FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
• FIGURE 35 SOFT TISSUE REPAIR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• FIGURE 36 SOFT TISSUE REPAIR MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024
• FIGURE 37 SOFT TISSUE REPAIR MARKET: IMPACT OF AI/GEN AI
• FIGURE 38 CANADA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
• FIGURE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
• FIGURE 40 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
• FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET, 2020-2024
• FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET (2024)
• FIGURE 43 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 44 SOFT TISSUE REPAIR MARKET: COMPANY FOOTPRINT
• FIGURE 45 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 46 EV/EBITDA OF KEY VENDORS
• FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 48 SOFT TISSUE REPAIR MARKET: R&D EXPENDITURE OF KEY PLAYERS (2023 VS. 2024)
• FIGURE 49 SOFT TISSUE REPAIR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 50 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
• FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
• FIGURE 52 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
• FIGURE 53 STRYKER: COMPANY SNAPSHOT
• FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT
• FIGURE 55 ZIMMER BIOMET: COMPANY SNAPSHOT
• FIGURE 56 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
• FIGURE 57 ARTIVION, INC.: COMPANY SNAPSHOT
• FIGURE 58 ORGANOGENESIS INC.: COMPANY SNAPSHOT
• FIGURE 59 BAXTER: COMPANY SNAPSHOT
• FIGURE 60 TISSUE REGENIX: COMPANY SNAPSHOT
• FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT

The soft tissue repair market is projected to reach USD 20.5 million by 2030 from USD 15.9 million in 2025, growing at a CAGR of 5.1 % from 2025 to 2030.

The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries.

The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions.

"By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024."

The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment's robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio.

"By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024."

In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market's expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market.

"By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024."

Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments-such as sports medicine, general surgery, and orthopedics-that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care.

"By region, Europe had the second-largest market share in the soft tissue repair market in 2024."

Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results.

A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-20%, Director Level 35%, and Others-45%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Others-18%.

Key players in the Soft tissue repair market are Smith & Nephew (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic (IE), Lifenet Health, Inc. (US), Becton, Dickinson and Company (US), Integra Lifesciences Corporation (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK), Aroa Biosurgery Ltd. (NZ), Artivion Inc. (US), CONMED Corporation (US), Meril Lifesciences Pvt Ltd. (India), RTI Surgical (US), Samyang Holdings Corporation (South Korea), Acera Surgical Inc. (US), Orthocell Ltd. (Australia), Biocer Entwicklungs Gmbh (Germany), Isto Biologics (US), Betatech Medical (Turkey), and Mimedx (US)

Research Coverage:

The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities)

Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region.

Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market.

Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.

Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market.

Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources of secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key industry insights
    • 2.1.2.5 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 REVENUE SHARE ANALYSIS
  • 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
  • 2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN)
  • 2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
  • 2.2.5 VOLUME ESTIMATION
• 2.3 GROWTH FORECAST
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 SCOPE-RELATED LIMITATIONS
  • 2.5.2 METHODOLOGY-RELATED LIMITATIONS
• 2.6 RISK ANALYSIS
• 2.7 STUDY ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SOFT TISSUE REPAIR MARKET OVERVIEW
• 4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX
• 4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024)
• 4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing geriatric population and rising prevalence of obesity
    • 5.2.1.2 Increasing occurrence of sports injuries
    • 5.2.1.3 Rise in R&D investments and launch of technologically advanced products
    • 5.2.1.4 High volume of surgeries and advancements in regenerative technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Unfavorable reimbursement scenario
    • 5.2.2.2 High cost of soft tissue repair products and surgical procedures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies
    • 5.2.3.2 Rising use of combination materials for enhancing product efficacy
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory framework
    • 5.2.4.2 Requirement of skilled personnel for effective use of soft tissue repair products
• 5.3 ECOSYSTEM ANALYSIS
  • 5.3.1 ROLE IN ECOSYSTEM
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022-2024
  • 5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
  • 5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022-2024
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 PATENT ANALYSIS
  • 5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
  • 5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
  • 5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET
  • 5.6.4 LIST OF MAJOR PATENTS
• 5.7 VALUE CHAIN ANALYSIS
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Stem cell and regenerative therapies
    • 5.8.1.2 Suture anchors and fixation devices
  • 5.8.2 ADJACENT TECHNOLOGIES
    • 5.8.2.1 3D bioprinting and tissue engineering
    • 5.8.2.2 Regenerative medicine and biologics
  • 5.8.3 COMPLEMENTARY TECHNOLOGIES
    • 5.8.3.1 Wound closure and hemostatic devices
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT DATA FOR HS CODE 300640, 2019-2023
  • 5.9.2 EXPORT DATA FOR HS CODE 300640, 2019-2023
• 5.10 KEY CONFERENCES & EVENTS, 2025-2026
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 REGULATORY FRAMEWORK
    • 5.11.1.1 North America
      • 5.11.1.1.1 US
      • 5.11.1.1.2 Canada
    • 5.11.1.2 Europe
    • 5.11.1.3 Asia Pacific
      • 5.11.1.3.1 China
      • 5.11.1.3.2 Japan
      • 5.11.1.3.3 India
    • 5.11.1.4 Latin America
      • 5.11.1.4.1 Brazil
      • 5.11.1.4.2 Mexico
    • 5.11.1.5 Middle East
    • 5.11.1.6 Africa
  • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12.3 BARGAINING POWER OF BUYERS
  • 5.12.4 BARGAINING POWER OF SUPPLIERS
  • 5.12.5 THREAT OF SUBSTITUTES
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 KEY BUYING CRITERIA
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
  • 5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
  • 5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 REIMBURSEMENT SCENARIO ANALYSIS
• 5.18 END-USER EXPECTATIONS
• 5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
• 5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON END-USE INDUSTRIES

6 SOFT TISSUE REPAIR MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 TISSUE PATCHES/MESHES
  • 6.2.1 SYNTHETIC MESHES
    • 6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth
  • 6.2.2 BIOLOGICAL MESHES
    • 6.2.2.1 Allografts
      • 6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants
    • 6.2.2.2 Xenografts
      • 6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures
  • 6.2.3 FIXATION PRODUCTS
    • 6.2.3.1 Suture anchors
      • 6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth
    • 6.2.3.2 Interference screws
      • 6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment
    • 6.2.3.3 Other fixation products
• 6.3 LAPAROSCOPIC INSTRUMENTS
  • 6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET
• 6.4 OTHER PRODUCTS

7 SOFT TISSUE REPAIR MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 HERNIA REPAIR
  • 7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH
• 7.3 SKIN REPAIR
  • 7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH
• 7.4 ORTHOPEDIC SOFT TISSUE REPAIR
  • 7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH
• 7.5 DENTAL SOFT TISSUE REPAIR
  • 7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH
• 7.6 BREAST RECONSTRUCTION
  • 7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH
• 7.7 DURAL REPAIR
  • 7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET
• 7.8 VAGINAL SLINGS
  • 7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH
• 7.9 OTHER APPLICATIONS

8 SOFT TISSUE REPAIR MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & CLINICS
  • 8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET
• 8.3 AMBULATORY SURGICAL CENTERS
  • 8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH
• 8.4 OTHER END USERS

9 SOFT TISSUE REPAIR MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American soft tissue repair market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth
  • 9.3.3 FRANCE
    • 9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth
  • 9.3.4 UK
    • 9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth
  • 9.3.5 ITALY
    • 9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Strong healthcare system and high geriatric population to favor market growth
  • 9.4.3 CHINA
    • 9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth
  • 9.4.4 INDIA
    • 9.4.4.1 Greater healthcare awareness and increased government support to aid market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of startups/SMEs
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 R&D EXPENDITURE
• 10.9 BRAND/PRODUCT COMPARISON
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES
  • 10.10.2 DEALS
  • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ARTHREX, INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 MnM view
      • 11.1.1.3.1 Right to win
      • 11.1.1.3.2 Strategic choices
      • 11.1.1.3.3 Weaknesses & competitive threats
  • 11.1.2 SMITH & NEPHEW PLC
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 JOHNSON & JOHNSON SERVICES, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 BECTON, DICKINSON AND COMPANY (BD)
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 MnM view
      • 11.1.4.3.1 Right to win
      • 11.1.4.3.2 Strategic choices
      • 11.1.4.3.3 Weaknesses & competitive threats
  • 11.1.5 STRYKER
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 MEDTRONIC
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
      • 11.1.6.3.2 Expansions
      • 11.1.6.3.3 Other developments
  • 11.1.7 ZIMMER BIOMET
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 INTEGRA LIFESCIENCES CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 ARTIVION, INC.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 ORGANOGENESIS INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 LIFENET HEALTH
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 BAXTER
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 TISSUE REGENIX
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 CONMED CORPORATION
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 MERIL LIFE SCIENCES PVT. LTD.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
  • 11.1.16 RTI SURGICAL
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 SAMYANG HOLDINGS CORPORATION
  • 11.2.2 AROA BIOSURGERY LIMITED
  • 11.2.3 ACERA SURGICAL INC.
  • 11.2.4 ORTHOCELL LTD.
  • 11.2.5 ACELL, INC.
  • 11.2.6 BIOCER ENTWICKLUNGS-GMBH
  • 11.2.7 ISTO BIOLOGICS
  • 11.2.8 BETATECH MEDICAL
  • 11.2.9 MIMEDX GROUP, INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS